PURCHASE, N.Y., Nov. 17, 2020 /PRNewswire/ -- PepsiCo, Inc.
(NASDAQ: PEP) today announced that Pietro Antonio Tataranni, MD has
been named the company's global Chief Medical Officer. As Chief
Medical Officer for PepsiCo, Dr. Tataranni will continue to oversee
all aspects of the company's efforts to protect its global
workforce, products and communities in the face of the COVID-19
pandemic. He will also continue to lead PepsiCo's Life Sciences
strategy and the R&D Fellows Program as its Executive Sponsor,
reporting to René Lammers, EVP & Chief Science Officer.
"We are pleased to announce the appointment of Antonio as our
Chief Medical Officer," said PepsiCo Chairman and CEO Ramon Laguarta. "Antonio has been a trusted
scientific and health advisor to PepsiCo's global leadership team
throughout the pandemic, and his counsel and leadership will
continue to be vital as we navigate the course ahead."
Since joining PepsiCo in September
2018, Dr. Tataranni has served as Deputy Chief Scientific
Officer and Senior Vice President of Life Sciences where he drives
the company's Nutrition Sciences, Sports Science and External
Innovation strategies, providing the unique expertise to interpret,
communicate and translate the science around physiology, diet and
health to guide innovation and portfolio transformation. Dr.
Tataranni also leads PepsiCo's scientific research agenda to build
recommendations and a future roadmap to enable disruptive product
innovations in line with PepsiCo's "Winning with Purpose" agenda.
Before PepsiCo, Dr. Tataranni worked at Sanofi as a Senior Vice
President and Head of Medical Affairs for the Diabetes and
Cardiovascular Business Unit. Prior to Sanofi, he worked as a
clinician, scientist, and physician at organizations including
Merck and the National Institute of Health (NIH).
"I am thrilled to take on this expanded role at PepsiCo, which
allows me to continue advancing our nutrition and bio-sciences
work, as well as advise the company on key health, science and
medical issues impacting our products, people and communities,"
said Dr. Tataranni. "PepsiCo has shown an unwavering dedication to
taking actions grounded in science, and I look forward to
continuing to work with the global leadership team in my new
capacity."
About PepsiCo
PepsiCo products are enjoyed by consumers more than one billion
times a day in more than 200 countries and territories around the
world. PepsiCo generated more than $67
billion in net revenue in 2019, driven by a complementary
food and beverage portfolio that includes Frito-Lay, Gatorade,
Pepsi-Cola, Quaker and Tropicana. PepsiCo's product portfolio
includes a wide range of enjoyable foods and beverages, including
23 brands that generate more than $1
billion each in estimated annual retail sales.
Guiding PepsiCo is our vision to Be the Global Leader in
Convenient Foods and Beverages by Winning with Purpose. "Winning
with Purpose" reflects our ambition to win sustainably in the
marketplace and embed purpose into all aspects of the
business. For more information, visit www.pepsico.com.
Contact:
Carrie Ratner
carrie.ratner@pepsico.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/pepsico-appoints-dr-pietro-antonio-tataranni-as-chief-medical-officer-301174469.html
SOURCE PepsiCo